Literature DB >> 18663464

Prognostic factors affecting oncologic outcomes in patients with locally recurrent rectal cancer: impact of patterns of pelvic recurrence on curative resection.

Jea-Kun Park1, Young-Wan Kim, Hyuk Hur, Nam-Kyu Kim, Byung-Soh Min, Seung-Kook Sohn, Young-Deuk Choi, Young-Tae Kim, Jung-Bai Ahn, Jae-Kyung Roh, Ki-Chang Keum, Jin-Sil Seong.   

Abstract

BACKGROUND: The purpose of this study is to investigate prognostic factors affecting oncologic outcomes in patients with locally recurrent rectal cancer and determine whether recurrence patterns influence curative resection of recurrent tumor.
MATERIALS AND METHODS: We examined 62 patients with isolated local recurrence following total mesorectal excision (TME) of the primary rectal cancer. Recurrence patterns were classified as central, anterior, posterior, lateral, and perineal with respect to the intra-pelvic tumor location. Prognostic factors affecting oncologic outcomes were analyzed, and the rate of curative resection was analyzed according to recurrence patterns.
RESULTS: The mean follow-up period was 49.0 +/- 29.0 months, and the mean time to recurrence after TME was 27.9 +/- 23.3 months. Twenty-three patients underwent curative resection, and the remaining 39 patients received palliative treatment. Patients with a central recurrence had the highest rate of curative resection (p = 0.006). The overall 5-year survival rate was 13.9% and significantly higher in those treated with curative resection (35.1%; p = 0.0002). Multivariate analysis demonstrated that disease-free survival less than 1 year and curative resection of local recurrence were independent prognostic factors influencing 5-year survival.
CONCLUSION: Patients with central recurrences have a high probability of curative resection. Disease-free survival less than 1 year and curative resection of local recurrence were independent prognostic factors affecting oncologic outcomes in patients with locally recurrent rectal cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18663464     DOI: 10.1007/s00423-008-0391-6

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  30 in total

1.  Predictors of survival in recurrent rectal cancer after resection and intraoperative radiotherapy.

Authors:  Margo Shoup; Jose G Guillem; Kaled M Alektiar; Kathy Liau; Philip B Paty; Alfred M Cohen; W Douglas Wong; Bruce D Minsky
Journal:  Dis Colon Rectum       Date:  2002-05       Impact factor: 4.585

2.  Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer.

Authors:  K Yamada; T Ishizawa; K Niwa; Y Chuman; S Akiba; T Aikou
Journal:  Br J Surg       Date:  2001-07       Impact factor: 6.939

3.  Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer in the pelvis.

Authors:  Yoshihiro Moriya; Takayuki Akasu; Shin Fujita; Seiichirou Yamamoto
Journal:  Dis Colon Rectum       Date:  2004-12       Impact factor: 4.585

4.  Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project.

Authors:  A L Martling; T Holm; L E Rutqvist; B J Moran; R J Heald; B Cedemark
Journal:  Lancet       Date:  2000-07-08       Impact factor: 79.321

Review 5.  Surgical management of locally recurrent rectal cancer.

Authors:  P M Sagar; J H Pemberton
Journal:  Br J Surg       Date:  1996-03       Impact factor: 6.939

6.  Mesorectal excision for rectal cancer.

Authors:  J K MacFarlane; R D Ryall; R J Heald
Journal:  Lancet       Date:  1993-02-20       Impact factor: 79.321

7.  Combination chemo-radiotherapy for residual, recurrent or inoperable carcinoma of the rectum: E.C.O.G. study (EST 3276).

Authors:  C E Danjoux; R D Gelber; G E Catton; D J Klaassen
Journal:  Int J Radiat Oncol Biol Phys       Date:  1985-04       Impact factor: 7.038

8.  Preoperative infusional chemoradiation, selective intraoperative radiation, and resection for locally advanced pelvic recurrence of colorectal adenocarcinoma.

Authors:  A M Lowy; T A Rich; J M Skibber; R A Dubrow; S A Curley
Journal:  Ann Surg       Date:  1996-02       Impact factor: 12.969

9.  Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer.

Authors:  K Suzuki; L L Gunderson; R M Devine; A L Weaver; R R Dozois; D M Ilstrup; J A Martenson; M J O'Connell
Journal:  Cancer       Date:  1995-02-15       Impact factor: 6.860

10.  Pelvic recurrence of rectal cancer. Options for curative resection.

Authors:  H J Wanebo; D L Gaker; R Whitehill; R F Morgan; W C Constable
Journal:  Ann Surg       Date:  1987-05       Impact factor: 12.969

View more
  12 in total

Review 1.  Surgery for Colorectal Cancer - Trends, Developments, and Future Perspectives.

Authors:  Markus Rentsch; Tobias Schiergens; Andrej Khandoga; Jens Werner
Journal:  Visc Med       Date:  2016-06-13

2.  Impact of anatomic location on locally recurrent rectal cancer: superior outcome for intraluminal tumour recurrence.

Authors:  Johannes Klose; Ignazio Tarantino; Thomas Schmidt; Thomas Bruckner; Yakup Kulu; Tobias Wagner; Martin Schneider; Markus W Büchler; Alexis Ulrich
Journal:  J Gastrointest Surg       Date:  2015-03-31       Impact factor: 3.452

3.  Comparison of three classifications for lymph node evaluation in patients undergoing total mesorectal excision for rectal cancer.

Authors:  Johannes Fritzmann; Pietro Contin; Christoph Reissfelder; Markus W Büchler; Jürgen Weitz; Nuh N Rahbari; Alexis B Ulrich
Journal:  Langenbecks Arch Surg       Date:  2018-03-09       Impact factor: 3.445

4.  Extended lateral pelvic sidewall excision (ELSiE): an approach to optimize complete resection rates in locally advanced or recurrent anorectal cancer involving the pelvic sidewall.

Authors:  I Shaikh; W Aston; G Hellawell; D Ross; S Littler; D Burling; M Marshall; J M A Northover; A Antoniou; J T Jenkins
Journal:  Tech Coloproctol       Date:  2014-11-08       Impact factor: 3.781

Review 5.  Surgical options for locally recurrent rectal cancer--review and update.

Authors:  A Troja; N El-Sourani; A Abdou; D Antolovic; H R Raab
Journal:  Int J Colorectal Dis       Date:  2015-05-20       Impact factor: 2.571

6.  Pelvic exenteration for advanced and recurrent malignancy.

Authors:  Evita Zoucas; Sven Frederiksen; Marie-Louise Lydrup; Wiking Månsson; Pelle Gustafson; Per Alberius
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

Review 7.  [Therapy of locally recurrent rectal carcinoma].

Authors:  H G Hempen; H R Raab
Journal:  Chirurg       Date:  2009-04       Impact factor: 0.955

8.  Impact of multimodal therapy in locally recurrent rectal cancer.

Authors:  Y N You; J M Skibber; C-Y Hu; C H Crane; P Das; E S Kopetz; C Eng; B W Feig; M A Rodriguez-Bigas; G J Chang
Journal:  Br J Surg       Date:  2016-03-02       Impact factor: 6.939

Review 9.  Intentionally curative treatment of locally recurrent rectal cancer: a systematic review.

Authors:  Pieter J Tanis; Annemiek Doeksen; J Jan B van Lanschot
Journal:  Can J Surg       Date:  2013-04       Impact factor: 2.089

Review 10.  Surgical treatment of locally recurrent rectal cancer: a narrative review.

Authors:  Zhaoya Gao; Jin Gu
Journal:  Ann Transl Med       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.